Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H.K. Lota, S. Ward, C. Nelson, P. Sestini, T.M. Maher, A.U. Wells, E.A. Renzoni (London, United Kingdom; Siena, Italy). Determinants of fitness to fly in interstitial lung disease. Eur Respir J 2012; 40: Suppl. 56, 690

Member's Comments

No comment yet.

Related content which might interest you: Characterization of emphysema in active farmer’s lung disease Source: International Congress 2016 – Occupational epidemiology Year: 2016 Monitoring of CF lung disease Source: ERS course 2015 Year: 2015 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Physiological responses to functional exercise capacity in interstitial lung disease patients with acute exacerbations Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015 The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 Biomarkers for interstitial lung disease Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease Year: 2016 Occupational interstitial lung disease Source: Eur Respir Mon; 2009: 46: 265–286 Year: 2009 Isolated reduction in residual volume on body plethysmography is an early indicator of parenchymal lung disease Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Predictors of quality of life in patients with interstitial lung disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Pulmonary vascular response patterns during exercise in interstitial lung disease Source: Eur Respir J 2015; 46: 738-749 Year: 2015 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Comparison of nutritional status in two systemic diseases involving respiratory system Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013